Position in CELC
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$275,882
-$30,698 QoQ
Shares Held
2,637
-1.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#201
of 273 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Saxony Capital Management, LLC holds $502,887 across 2 Biotechnology names. CELC ranks #1 (54.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
This page
|
2,637 | $275,882 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
457 | $227,005 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $275,882 | 2,637 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $306,580 | 2,686 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $251,344 | 2,520 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||